36 participants
Iparomlimab and Tovorilimab (QL1706) Combined With Bevacizumab and Chemotherapy as Neoadjuvant Therapy for Advanced Ovarian Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-23
- Start Date:
- 2026-07-31
- Completion:
- 2029-04-30
Conditions
- Ovarian Cancers
Interventions
- DRUG
No Results Yet